27 jun: IWC lancerer Big Pilot special edition i anledning af EM i fodbol..
28 jun: Når lav risiko giver højt afkast
27-06-2012 23:56:00

WSJ BLOG/Health: Pharmacies Try Offering Free HIV Testing

(This story has been posted on The Wall Street Journal Online's Health Blog at http://blogs.wsj.com/health.)

By Timothy W. Martin

Pharmacists and other drugstore staff already conduct tests for high-blood pressure, cholesterol levels and diabetes at in-store clinics.

Now, in a pilot program with federal health officials announced Tuesday, Walgreen Co. and other pharmacies will examine whether they can become a go-to stop for those seeking HIV testing.

So far, seven stores -- including three operated by Walgreen in Chicago, Washington D.C. and Lithonia, Ga. -- are offering the HIV tests for free. Spotting a patient early on with HIV decreases the likelihood the disease will be transmitted to other people and helps get an infected individual on drug treatment and therapy earlier.

By the end of the summer, the Centers for Disease Control and Prevention plans to add 17 more pharmacies to the pilot program, dividing the participating drug stores equally between urban and rural locations.

The CDC estimates 1.1 million people in the U.S. live with HIV, but nearly one in five of those infected is unaware of their condition. Health officials six years ago recommended that all adolescents and adults between the ages of 13 to 64 get tested at least once for HIV.

Testing numbers have risen in recent years. About 45% of Americans aged 18 to 64 in 2009 had reported getting tested for HIV at some point in their lives, according to CDC research, up from the 40% observed in 2006.

The two-year pilot is a test run for how drug stores and community pharmacies across the country could one day offer HIV testing. CDC officials will study the amount of time, resources and cost required.

"We want to get a sense of how cumbersome this process would be and the approximate cost of the service for the pharmacies," Kevin Fenton, a CDC director for the center focusing on HIV/AIDS, tells the Health Blog.

The findings will help health officials establish a model that other pharmacies could follow, says Paul Weidle, the CDC epidemiologist in charge of the project.

Free HIV tests are widely available at local health departments and community organizations. Most people get tested at their doctor's office as part of routine health screens, paying a nominal fee for the test or the visit. Test samples are collected by oral swab or from a blood sample taken by a finger prick device.

Pharmacists or nurse practitioners at the pilot clinics use an oral swab of the gums or inside the cheek. The FDA-approved HIV tests produce results within 20 minutes. If the test comes out as a preliminary positive, the patient will be referred to a local health-care provider for confirmation and care.

The tests are conducted in private rooms. "This is a non-descript type of place. Nobody really knows what you're in there for," said Mike Ellis, Walgreen's vice president of specialty and infusion.

Walgreen has also trained its pharmacists in recent years to take tests for blood pressure, cholesterol and diabetes. The pharmacists who can provide counseling about HIV treatments or conduct a test receive about 25 hours of training every year, said Glen Pietrandoni, senior manager of HIV/AIDS and Hepatitis at Walgreen.

-For continuously updated news from The Wall Street Journal, see WSJ.com at http://wsj.com.

(END) Dow Jones Newswires

June 27, 2012 17:56 ET (21:56 GMT)

Copyright (c) 2012 Dow Jones & Company, Inc.

Opret kommentar

Relateret debat

  • 1 uge
  • 1 måned
  • 1 År
18 jan
OMXC25
@ Poppelkongen: Jeg tror ski da, at du har misforstået brugen af filteret?! Når du nævner, at du er..
37
17 jan
 
Hej alle,   Nu hvor jeg tager et sabat-år som investor i 2018, tænkte jeg, at jeg ville lave en upda..
26
19 jan
 
Jeg har på en fornemmelsen at i ikke bryder jer om mig? Ik sandt? Så har overvejet at stoppe på EI. ..
24
20 jan
 
Jeg stiller mig tvivlende,,,,,: At som dansk at betale til Prins Henrik & Co der skider DK en hatful..
19
15 jan
BEO-SDB
Godmorgen,   Som langt størstedelen af jer der har investeret i BEO ved, afventer vi svar fra Bergst..
18
19 jan
 
Måske du bare skulle revurdere din adfærd og generelle ageren?
16
15 jan
VWS
Vi har snakker Vestas Service en gang i dag, men jeg tror, at selv Vestas Group er overrasket over, ..
16
20 jan
TEVA
Mit råd er at lade være med at lytte til andre. Beslut dig, hvad du synes Teva er værd. Hvis den nuv..
15
18 jan
VWS
Utroligt, at det nu i flere år har været muligt og lovligt at handle under dæknavnet "Anonymous Brok..
15
19 jan
NOVO-B
Novo/Goldman: Kursmålet hæves med godt 30 pct. 19/1/2018 06.34· Ritzau Finans Den danske medicinalgi..
14

Novo Nordisk/Goldman: Diabetestablet vil få den høje vækst tilbage

19-01-2018 15:11:36
Novo Nordisk står med et meget stærkt kort på hånden, hvis selskabet får en tabletudgave af det store væksthåb Ozempic (Semaglutid) godkendt og sendt på markedet.Det mener den amerikanske investeringsbank Goldman Sachs, der vurderer, at investorerne på aktiemarkedet ikke har taget tilstrækkeligt højde for de store muligheder for diabetesmidlet.Derfor har banken hævet sit kursmål for Novo Nordisk-a..

WDH/SEB: Amerikansk høreapparatmarked vokser mere end ventet

19-01-2018 14:35:39
Der var mere fart på den private del af det amerikanske høreapparatmarked i slutningen af 2017, end den svenske bank SEB havde ventet.Det skriver Bloomberg News på baggrund af en analyse fra SEB.Den private del af det amerikanske høreapparatmarked voksede 7,3 pct. i fjerde kvartal mod 2,8 pct. i tredje kvartal ifølge tal fra American Hearing Aid Association. Det var højere, end SEB har ventet, og ..

Aktier/åbning: Børshuse skubber Chr. Hansen og Novo til tops

19-01-2018 09:23:02
Chr. Hansen og Novo Nordisk er strøget til tops på det danske aktiemarked og medvirker til at hive det danske C25-indeks i et solidt plus fredag morgen.Stemningen var ellers svagt negativ i futuremarkedet indtil kort før åbningen.C25-indekset stiger 0,5 pct. til 1160,09 og ligger til et samlet plus på 0,8 pct. i denne uge.Især Chr. Hansen er sprunget i vejret fra åbningen. Aktien stiger 3,9 pct. t..

Mest læste nyheder

  • 24 timer
  • 48 timer
  • 1 uge
1
Genmab får hastebehandlet Darzalex-ansøgning i USA
2
Aktier/tendens: Genmab kan tage fokus i forventet nervøs åbning
3
Genmab: Partner indstiller markedsføring af Arzerra i CLL uden for USA
4
Sanofi køber Bioverativ for 11,6 mia. dollar
5
USA står op til lammet statsapparat efter udskudt afstemning

Køb- og salgsanbefalinger

  • Trend
  • Pengemaskinen

Copyright Euroinvestor A/S 2018  Disclaimer Privatlivspolitik
Aktieinformation leveres af Morningstar.
Data er forsinket 15-20 minutter iht. de enkelte børsers regler om videredistribution.
 
22. januar 2018 09:03:08
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: LiveBranchBuild_20180112.1 - EUROWEB1 - 2018-01-22 09:03:08 - 2018-01-22 09:03:08 - 1 - Website: OKAY